Home > PJ > Contents

The Pharmaceutical Journal, August 18, 2001

Back issues

Previous  Next

Return to PJ Online Home Page

Leading Article   
   Problems with drug withdrawals

News & Features   
   News

   Cerivastatin withdrawal: the impacts [more]

   Where do generic and brand names come from? [more]

Comment   
   Broad Spectrum: Only radical change can tackle community pharmacist workload and shortages [more]

   Letters to the Editor

Continuing Education   
   Management of incontinence
   »(PDF*, 55K)

Articles   
   Pharmacy must be represented when the balance of power is shifted [more]
   Managing medicines better — smarter purchasing and distribution [more]

Original Papers
   
   An intervention to increase antiplatelet aspirin prescribing in patients with cardiovascular disease in East London and the City
   »(PDF*, 60K)

Onlooker

The Society   
   News
   August Council meeting
   Statutory committee
   Obituaries & tributes
   
Notice-board
   Future events
   Conferences
and more

Products


* PDFs require Acrobat Reader 4 or later

Front Cover Picture
This week’s front cover picture (by Christopher Icha) ties in with a news feature in which Frances Thompson looks at how drugs and branded medicines get their names.

Professional regulation
The Government has begun its consultation on proposals to create a Council for the Regulation of Health Professionals, including pharmacists.

Cerivastatin
Clare Bellingham examines the impacts of Bayer’s recent withdrawal from the market of cerivastatin. Leading article.

Incontinence management
Ways in which pharmacists can help people with incontinence are examined in this week’s continuing education article.

Managing medicines better
The Adam Smith Institute has been developing a blueprint for the reform of British health care. In an article this week, it outlines its proposals for smarter medicine purchasing and distribution.

Infant milk recall
SMA Nutrition is recalling some batches of Gold and White infant milk formula powder as a precautionary measure, following a recent case of infant botulism.


©The Pharmaceutical Journal